Bioanalytical Systems (NASDAQ:BASI) Announces Quarterly Earnings Results

Bioanalytical Systems (NASDAQ:BASI) issued its earnings results on Wednesday. The company reported ($0.04) earnings per share for the quarter, reports. The company had revenue of $10.86 million for the quarter. Bioanalytical Systems had a negative net margin of 2.82% and a negative return on equity of 3.12%.

NASDAQ BASI traded down $0.03 on Thursday, hitting $2.07. The company’s stock had a trading volume of 64,670 shares, compared to its average volume of 9,252. Bioanalytical Systems has a 52-week low of $1.18 and a 52-week high of $2.17. The company has a debt-to-equity ratio of 0.91, a quick ratio of 0.54 and a current ratio of 0.63. The firm’s 50-day simple moving average is $2.01.

Separately, ValuEngine cut Bioanalytical Systems from a “buy” rating to a “hold” rating in a report on Tuesday, August 6th.

An institutional investor recently raised its position in Bioanalytical Systems stock. Renaissance Technologies LLC grew its holdings in Bioanalytical Systems, Inc. (NASDAQ:BASI) by 7.7% in the 2nd quarter, according to the company in its most recent filing with the SEC. The firm owned 253,001 shares of the company’s stock after buying an additional 18,120 shares during the quarter. Renaissance Technologies LLC owned approximately 2.46% of Bioanalytical Systems worth $506,000 at the end of the most recent quarter. 6.02% of the stock is owned by institutional investors and hedge funds.

Bioanalytical Systems Company Profile

Bioanalytical Systems, Inc provides drug discovery and development services, and analytical instruments for pharmaceutical, biotechnology, academic, and government organizations in the United States, rest of North America, the Pacific Rim, Europe, and internationally. It operates through two segments, Contract Research Services and Research Products.

Recommended Story: Why is insider trading harmful?

Earnings History for Bioanalytical Systems (NASDAQ:BASI)

Receive News & Ratings for Bioanalytical Systems Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bioanalytical Systems and related companies with's FREE daily email newsletter.